Sign in

You're signed outSign in or to get full access.

Matthew J. Lustig

Director at Ventas
Board

About Matthew J. Lustig

Independent director at Ventas since 2011; age 64 as of the 2025 Annual Meeting. Lustig chairs the Board’s Investment Committee and brings 35+ years of real estate advisory and principal investing experience, currently serving as Chairman of Investment Banking, North America at Lazard Frères & Co. LLC and Head of Real Estate & Lodging, with an active role across $400B+ of advisory assignments; he previously oversaw Lazard Senior Housing Partners with $2.5B+ of equity invested in REITs and real estate operating companies .

Past Roles

OrganizationRoleTenureCommittees/Impact
Lazard Frères & Co. LLCChairman of Investment Banking, North America2019–presentSenior leadership over investment banking NA; Head of Real Estate & Lodging since 1989
Lazard Frères & Co. LLCHead of Investment Banking, North America2012–2019Oversight of investment banking NA
Lazard private equity real estateChief Executive Officer1999–2022Led private equity real estate investment business and successors
Atria Senior Living, Inc.Executive Chairman of Board2004–2011For‑profit senior housing operator governance leadership

External Roles

OrganizationRoleTenureNotes
Boston Properties, Inc. (NYSE: BXP)Director2011–presentCurrent public company directorship
Wharton Zell/Lurie Real Estate CenterMember; former Executive Committee ChairOngoingAcademic/industry governance
Georgetown Univ. Walsh School of Foreign ServiceBoard of AdvisorsOngoingAdvisory role
Columbia Business School Paul Milstein CenterMBA Real Estate Program Advisory BoardOngoingAdvisory role
Council on Foreign Relations; PREA; Real Estate Roundtable; ULIMemberOngoingIndustry policy/real estate bodies

Board Governance

  • Committee assignments: Investment Committee Chair; not listed on Audit or Compensation committees .
  • Independence: Board determined all directors except the CEO are independent; specific review affirmed Lustig’s independence despite Lazard’s ordinary-course advisory relationship due to immateriality, lack of involvement, and amounts well below NYSE thresholds. In 2024 the Board adopted a policy not to engage any entity employing a director full-time for transactional advisory (acquisitions, dispositions, restructurings, JVs), further mitigating conflicts .
  • Attendance and engagement: Board held 7 meetings in 2024; each incumbent director attended >75% of Board and committee meetings, with average attendance of 98%. Independent directors meet in executive session at each regular Board and committee meeting .
  • Investment Committee activity: The committee met 2 times in 2024 and oversees transaction-related risks and approvals per the Company’s Investment and Divestiture Approval Procedures .

Fixed Compensation

YearCash Fees EarnedNotes
2024$126,250 Includes base retainer and chair/member fees; Lead Independent Director supplement applies to another director
2023$125,000 Base retainer and committee fees under prior program

Program detail (effective Oct 1, 2024):

  • Annual cash retainer: $110,000; Investment Committee Chair supplement: $20,000; Investment Committee member supplement: $15,000; excess meeting fee: $1,500 per meeting beyond thresholds .
  • Director stock ownership guideline: minimum 5x annual cash retainer; all non‑employee directors in compliance (considering transition for new directors) .

Performance Compensation

YearStock Awards (Grant Date Fair Value)Unvested RSUs at 12/31Vesting & Deferral
2024$174,958 3,648 units Annual RSU grants typically vest on the first anniversary or next annual meeting; directors may defer receipt beyond vesting
2023$174,991 5,363 units RSU structure under prior program

Additional incentives:

  • Annual equity award program value increased by $10,000 to $185,000 effective Oct 1, 2024 (applies at program level; grant-date fair value may differ with stock price) .
  • Deferred compensation elections: Lustig deferred 2024 cash fees into 2,479 stock units and 2023 cash fees into 2,817 stock units .
  • No options or PSUs for directors; director equity is time-based RSUs, not performance-conditioned .

Other Directorships & Interlocks

CompanySectorRolePotential Interlock
Boston Properties (BXP)Office REITDirectorNo shared public board disclosed with other Ventas directors; not a direct healthcare REIT competitor

Expertise & Qualifications

  • Real estate and REIT investing; capital allocation; financial/accounting expertise; healthcare/senior housing industry knowledge; risk management and strategic planning. Overseen multiple funds including Lazard Senior Housing Partners and played active roles in $400B+ of real estate advisory/transactions .

Equity Ownership

HolderCommon SharesOptions (60-day exercisable)Stock Units (settle within 60 days)Total Beneficially Owned% of Shares Outstanding
Matthew J. Lustig12,387 70,130 82,517 <1% (group 0.8% for 16 persons)
All directors & officers (16 persons)1,754,294 1,099,093 607,710 3,461,097 0.8%

Alignment and restrictions:

  • Ownership guideline: minimum 5x annual cash retainer; in compliance .
  • Securities trading policy prohibits hedging, short sales, and pledging/margin accounts; no director or executive officer hedged or pledged Company securities in 2024 .

Governance Assessment

  • Strengths: Deep sector expertise, long-tenured committee leadership in investments, high attendance culture, robust independence framework, and strong ownership alignment through RSUs and deferrals .
  • Conflict mitigants: Specific independence determination addressing Lazard; policy barring engagement of entities employing directors for transactional advisory; no related‑party transactions in 2024 .
  • Shareholder signals: Say‑on‑pay support over 86% in 2024 and over 90% in 2023, and active Board‑led shareholder outreach, supporting investor confidence in governance and pay practices .

RED FLAGS: None disclosed for Lustig—no related‑party transactions, hedging/pledging, or attendance shortfalls reported; independence addressed with policy safeguards .